06 Sep, 2019 Read Time: 3 mins Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Parkinson's Disease Article New therapeutic technologies and targets for Parkinson’s disease Schizophrenia Article COVID-19: Pandemic brings challenge and opportunity for people with schizophrenia (including telemedicine!) Depression Article One size does not fit all…or does it?: Heterogeneity within depression
